1. Home
  2. MMSI vs KRYS Comparison

MMSI vs KRYS Comparison

Compare MMSI & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMSI
  • KRYS
  • Stock Information
  • Founded
  • MMSI 1987
  • KRYS 2015
  • Country
  • MMSI United States
  • KRYS United States
  • Employees
  • MMSI N/A
  • KRYS N/A
  • Industry
  • MMSI Medical/Dental Instruments
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MMSI Health Care
  • KRYS Health Care
  • Exchange
  • MMSI Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • MMSI 5.3B
  • KRYS 4.3B
  • IPO Year
  • MMSI 1990
  • KRYS 2017
  • Fundamental
  • Price
  • MMSI $92.97
  • KRYS $150.27
  • Analyst Decision
  • MMSI Buy
  • KRYS Strong Buy
  • Analyst Count
  • MMSI 9
  • KRYS 10
  • Target Price
  • MMSI $107.00
  • KRYS $204.90
  • AVG Volume (30 Days)
  • MMSI 465.4K
  • KRYS 258.6K
  • Earning Date
  • MMSI 10-29-2025
  • KRYS 11-03-2025
  • Dividend Yield
  • MMSI N/A
  • KRYS N/A
  • EPS Growth
  • MMSI N/A
  • KRYS 36.22
  • EPS
  • MMSI 1.97
  • KRYS 4.91
  • Revenue
  • MMSI $1,432,816,000.00
  • KRYS $359,205,000.00
  • Revenue This Year
  • MMSI $12.79
  • KRYS $34.33
  • Revenue Next Year
  • MMSI $6.34
  • KRYS $47.84
  • P/E Ratio
  • MMSI $46.72
  • KRYS $30.70
  • Revenue Growth
  • MMSI 10.11
  • KRYS 116.08
  • 52 Week Low
  • MMSI $81.04
  • KRYS $122.80
  • 52 Week High
  • MMSI $111.45
  • KRYS $207.84
  • Technical
  • Relative Strength Index (RSI)
  • MMSI 66.37
  • KRYS 55.22
  • Support Level
  • MMSI $89.30
  • KRYS $145.47
  • Resistance Level
  • MMSI $91.30
  • KRYS $152.57
  • Average True Range (ATR)
  • MMSI 1.72
  • KRYS 4.10
  • MACD
  • MMSI 0.64
  • KRYS 0.33
  • Stochastic Oscillator
  • MMSI 96.32
  • KRYS 74.26

About MMSI Merit Medical Systems Inc.

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: